Report Urges Swift Compensation for Epilepsy Drug and Pelvic Mesh Victims

The Patient Safety Commissioner for England, Dr. Henrietta Hughes, has called for immediate financial support for the children disabled by the epilepsy medication sodium valproate and women harmed by pelvic mesh implants. Following a review that revealed lives were devastated due to ignored warnings about these treatments, the government is now considering her recommendations for action.

Roughly 20,000 children have been born with disabilities since the 1970s after being exposed to sodium valproate in the womb, despite research from the 1980s indicating the drug's risk to developing babies. Warnings were not routinely included on packaging until 2016, leading to families campaigning for awareness, compensation, and an inquiry for decades.

Furthermore, around 127,000 women received mesh implants for pelvic organ prolapse and incontinence between 2008 and 2017, resulting in permanent pain and disability for some. Dr. Hughes suggests that the government should award initial payments of £100,000 to sodium valproate victims and £20,000 to those injured by mesh, followed by additional support.

Dr. Hughes compared the magnitude of the sodium valproate scandal to the infamous thalidomide crisis and emphasized justice for the families who have long fought for recognition and assistance. The proposed compensation scheme addresses the suffering and lifelong care commitments faced by affected families.

Emma Friedmann, a mother whose son was born with foetal valproate syndrome, expresses her guilt and skepticism about receiving compensation after the profound impact on her son's independence and ability to provide for her family. Even with new regulations, about three babies a month are still born with defects from the drug.

Similarly, women injured by pelvic mesh, like Sadie Lambourne from Yeovil, speak of their loss of independence and the significant physical and financial strains caused by the implants. A 2020 review found the complications from pelvic mesh to be entirely preventable, linking the issues to systemic healthcare failings.

Women's Health Minister Maria Caulfield acknowledges the affected individuals and emphasizes ongoing efforts to improve patient-professional communication and the safety of medical treatments.